Literature DB >> 12650946

Identification of three novel Smad binding proteins involved in cell polarity.

Dennis R Warner1, M Michele Pisano, Emily A Roberts, Robert M Greene.   

Abstract

A yeast two-hybrid screen was utilized to identify novel Smad 3 binding proteins expressed in developing mouse orofacial tissue. Three proteins (Erbin, Par-3, and Dishevelled) were identified that share several similar structural and functional characteristics. Each contains at least one PDZ domain and all have been demonstrated to play a role in the establishment and maintenance of cell polarity. In GST (glutathione S-transferase) pull-down assays, Erbin, Par-3, and Dishevelled bound strongly to the isolated MH2 domain of Smad 3, with weaker binding to a full-length Smad 3 protein. Failure of Erbin, Par-3, and Dishevelled to bind to a Smad 3 mutant protein that was missing the MH2 domain confirms that the binding site resides within the MH2 domain. Erbin, Par-3, and Dishevelled also interacted with the MH2 domains of other Smads, suggesting broad Smad binding specificity. Dishevelled and Erbin mutant proteins, in which the PDZ domain was removed, still retained their ability to bind Smad 3, albeit with lower affinity. While transforming growth factor beta (TGFbeta) has been suggested to alter cell polarity through a Smad-independent mechanism involving activation of members of the RhoA family of GTP binding proteins, the observation that Smads can directly interact with proteins involved in cell polarity, as shown in the present report, suggests an additional means by which TGFbeta could alter cell polarity via a Smad-dependent signaling mechanism.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12650946     DOI: 10.1016/s0014-5793(03)00155-8

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  19 in total

1.  Identification of a novel Wnt5a-CK1ɛ-Dvl2-Plk1-mediated primary cilia disassembly pathway.

Authors:  Kyung Ho Lee; Yoshikazu Johmura; Li-Rong Yu; Jung-Eun Park; Yuan Gao; Jeong K Bang; Ming Zhou; Timothy D Veenstra; Bo Yeon Kim; Kyung S Lee
Journal:  EMBO J       Date:  2012-05-18       Impact factor: 11.598

Review 2.  The leucine-rich repeat signaling scaffolds Shoc2 and Erbin: cellular mechanism and role in disease.

Authors:  HyeIn Jang; Payton Stevens; Tianyan Gao; Emilia Galperin
Journal:  FEBS J       Date:  2020-07-06       Impact factor: 5.542

3.  Smurf1 regulates neural patterning and folding in Xenopus embryos by antagonizing the BMP/Smad1 pathway.

Authors:  Evguenia M Alexandrova; Gerald H Thomsen
Journal:  Dev Biol       Date:  2006-08-10       Impact factor: 3.582

4.  Bone morphogenetic proteins regulate neural tube closure by interacting with the apicobasal polarity pathway.

Authors:  Dae Seok Eom; Smita Amarnath; Jennifer L Fogel; Seema Agarwala
Journal:  Development       Date:  2011-08       Impact factor: 6.868

Review 5.  New Player in Endosomal Trafficking: Differential Roles of Smad Anchor for Receptor Activation (SARA) Protein.

Authors:  Victoria Rozés-Salvador; Sebastian O Siri; Melina M Musri; Cecilia Conde
Journal:  Mol Cell Biol       Date:  2018-11-28       Impact factor: 4.272

6.  TGFbeta promotes Wnt expression during cataract development.

Authors:  C C W Chong; R J W Stump; F J Lovicu; J W McAvoy
Journal:  Exp Eye Res       Date:  2008-08-26       Impact factor: 3.467

7.  Genome-wide impact of the BRG1 SWI/SNF chromatin remodeler on the transforming growth factor beta transcriptional program.

Authors:  Qiaoran Xi; Wei He; Xiang H-F Zhang; Hong-Van Le; Joan Massagué
Journal:  J Biol Chem       Date:  2007-11-14       Impact factor: 5.157

8.  Erbin inhibits transforming growth factor beta signaling through a novel Smad-interacting domain.

Authors:  Fangyan Dai; Chenbei Chang; Xia Lin; Penggao Dai; Lin Mei; Xin-Hua Feng
Journal:  Mol Cell Biol       Date:  2007-06-25       Impact factor: 4.272

9.  Identification of novel Smad2 and Smad3 associated proteins in response to TGF-beta1.

Authors:  Kimberly A Brown; Amy-Joan L Ham; Cara N Clark; Nahum Meller; Brian K Law; Anna Chytil; Nikki Cheng; Jennifer A Pietenpol; Harold L Moses
Journal:  J Cell Biochem       Date:  2008-10-01       Impact factor: 4.429

10.  FcγRI is required for TGFβ2-treated macrophage-induced tolerance.

Authors:  Z Gu; A Y Chhabra; P Alard; D R Warner; M M Kosiewicz
Journal:  Immunobiology       Date:  2013-04-12       Impact factor: 3.144

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.